Burnett D - Search Results

1

A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancer.

Chiappori AA, Ellis PM, Hamm JT, Bitran JD, Eiseman I, Lovalvo J, Burnett D, Olson S, Lenehan P, Zinner RG. Chiappori AA, et al. Among authors: burnett d. J Thorac Oncol. 2006 Nov;1(9):1010-9. J Thorac Oncol. 2006. PMID: 17409987 Free article. Clinical Trial.

2

Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.

Takasaki H, Uchida E, Tempero MA, Burnett DA, Metzgar RS, Pour PM. Takasaki H, et al. Among authors: burnett da. Cancer Res. 1988 Mar 15;48(6):1435-8. Cancer Res. 1988. PMID: 3162196

3

High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies.

Barbasch A, Higby DJ, Brass C, Bakri K, Karakousis C, Pontes JE, Wajsman LZ, Beckley S, Freeman A, Killion K, Burnett D. Barbasch A, et al. Among authors: burnett d. Cancer Treat Rep. 1983 Feb;67(2):143-8. Cancer Treat Rep. 1983. PMID: 6337711

4

Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue.

Takasaki H, Tempero MA, Uchida E, Büchler M, Ness MJ, Burnett DA, Metzgar RS, Colcher D, Schlom J, Pour PM. Takasaki H, et al. Among authors: burnett da. Int J Cancer. 1988 Nov 15;42(5):681-6. doi: 10.1002/ijc.2910420508. Int J Cancer. 1988. PMID: 3053465

5

Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.

Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Pour PM, et al. Among authors: burnett da. Cancer Res. 1988 Oct 1;48(19):5422-6. Cancer Res. 1988. PMID: 3166398

6

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.

Tempero MA, Uchida E, Takasaki H, Burnett DA, Steplewski Z, Pour PM. Tempero MA, et al. Among authors: burnett da. Cancer Res. 1987 Oct 15;47(20):5501-3. Cancer Res. 1987. PMID: 3308077

7

Blood-group antigen expression during pancreatic cancer induction in hamsters.

Pour PM, Uchida E, Burnett DA, Steplewski Z. Pour PM, et al. Among authors: burnett da. Int J Pancreatol. 1986 Dec;1(5-6):327-40. doi: 10.1007/BF02801865. Int J Pancreatol. 1986. PMID: 3316427

8

Correlative studies on antigenicity of pancreatic cancer and blood group types.

Uchida E, Tempero MA, Burnett DA, Steplewski Z, Pour PM. Uchida E, et al. Among authors: burnett da. Cancer Detect Prev Suppl. 1987;1:145-8. Cancer Detect Prev Suppl. 1987. PMID: 3319143

9

Presence of two distinct acinar cell populations in human pancreas based on their antigenicity.

Uchida E, Steplewski Z, Mroczek E, Büchler M, Burnett D, Pour PM. Uchida E, et al. Among authors: burnett d. Int J Pancreatol. 1986 Oct;1(3-4):213-25. doi: 10.1007/BF02795247. Int J Pancreatol. 1986. PMID: 3316426

10

Lectin binding affinities of induced pancreatic lesions in the hamster model.

Pour PM, Burnett D, Uchida E. Pour PM, et al. Among authors: burnett d. Carcinogenesis. 1985 Dec;6(12):1775-80. doi: 10.1093/carcin/6.12.1775. Carcinogenesis. 1985. PMID: 4064253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

581 results

Search Page

Filters